chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Narrative: ADMISSION DATE: 8/7/21 DISCHARGE DATE: 8/11/21 DISCHARGE TYPE: Regular PRINCIPAL DIAGNOSIS (Reason for admission after study): Acute COVID 19 infection AKI on chronic stage IIIA CKD - resolved Acute on chronic anemia due to menorrhagia Hyperkalemia - resolved Type II DM HISTORY OF PRESENT ILLNESS : Patient is a 45 year old with a PMH notable for CAD, CRI, GERD, Hypertension, DM Type 2, Leiomyoma, Gastrooparesis, depression, shoulder pain, insomnia admitted via ED for Covid positive and acute on chronic renal insufficiency with hyperkalemia. Patient who was recently exposed to her Covid positive daughter presents for evaluation of increased sinus pressure, sore throat and cough that started on Tuesday. She was vaccinated with Pfizer/Covid vaccine on June 9 and July 6. She denies any shortness of breath, chest pain, vomiting or diarrhea. She also reports right thigh pain secondary to falling out of bed and hitting her right upper thigh. Per patient a large bruise had developed on her leg and she has pain with movement and elevation of right leg. Patient states she applied muscle cream to leg with minimal relief. HOSPITAL COURSE: a 45 yo woman with a hx of Stage IIIA CKD, CAD, anemia, HTN, Type II DM complicated by gastroparesis s/p pacer, who was admitted on 8/9/21 with AKI and an acute COVID 19 infection. She was admitted to the medical floor on airborne precautions. Although a chest CT showed evidence of ground glass opacities, decadron and remdesvir were not started since the patient had no hypoxia during this hospitalization. Pt with AKI on chronic stage IIIA CKD, cr on admission was 3.1 which improved to 2.2 with IVF hydration. Pt with acute on chronic anemia, hgb dropped to 7.0 due to menorrhagia.S/P tx of 2 unit prbc this admission with repeat hgb 10. Plan for outpt follow up with Gyn.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 66 years old female patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or about 03-DEC-2014, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route not specified) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date, the patient experienced shingles. On an unspecified date, the patient was treated by a physician assistant for shingles. The outcome of the event shingles was not reported. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).   Additional information has been requested.
After duing light work on Saturday morning. I sat down for a few minutes and felt a little light headed.  My stomach became quisy and I had to go into the bathroom, became nauseated and had to vomit. I had a quisy stomach most of the balance of the day.  I experiecnced a restless night. However, by mid-morning  Sunday I began to feel better and have had no additonal inegative effect.  The only other  unexplained  item was that on Sunday I checked my blood presure and it was 154/ 85. This is very unusual,  as due to the nifedipine I take for my DES, my average for years is around 125/80.  Today, Tuesday, I checked it again and it still  at 158/87.  I have an appointment with my cardiologist  in 2 weeks and will discuss this with him.
Arm is red, aching, circular, raised, hard, growing slightly, warm, and itches.  Also feels itching in her throat, and allergies are acting up.  Patient took benadryl cream along with antihistamine she usually takes.Continue using cream for symptomatic relief, if symptoms worsen feel free to call back or see your PCP.  We will follow up in 2 days at around the same time.
Extreme dizziness at first; followed by severe flu-like symptoms (i.e. muscle soreness throughout body, aches throughout body, fever between 99 and 101 degrees, etc.) lasting more than 3 days.
A person who was fully vaccinated and caught covid.; A person who was fully vaccinated and caught covid.; This is a spontaneous report from a non-contactable consumer (patient). A patient of unspecified age and gender received and first dose of bnt162b2 (COVID-19 VACCINE - MANUFACTURER UNKNOWN, lot number was not reported) via an unspecified route of administration on an unspecified date as dose 1, single and second dose of bnt162b2 (COVID-19 VACCINE - MANUFACTURER UNKNOWN, lot number was not reported) via an unspecified route of administration on an unspecified date as dose 2, single both for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Reported Event that video (link content) shows a person who was fully vaccinated and caught covid. I am unsure of the type of vaccine received. The video explains progression of symptoms. On an unspecified date, the patient experienced a person who was fully vaccinated and caught covid. No seriousness criteria were reported. The patient underwent lab tests and procedures which included sars-cov-2 test: which resulted as covid post vaccination. The outcome of the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
nasal congestion Narrative: Staff was alerted initially with concerns for feeling winded. On further evaluation, this was clarified as feeling like air was not passing through his nasal passages as easily. Issue began about 20 minutes after vaccination. He denied swelling, difficulty swallowing, urticaria/flushing, pruritus, confusion, dizziness/lightheadedness, shortness of breath, wheezing, palpitations, nausea or feeling like he needed to vomit/have diarrhea. Patient has experienced some nasal congestion in the past, which this feels more similar to than difficulty breathing. No issues reported after first COVID-19 vaccination or similar adverse effects from other vaccinations in the past. O: HR 67 BP 120/73 SpO2 98% on RA Gen: not in distress/non-toxic, answering questions appropriately, pleasant, speaking in full sentences w/o increased work of breathing HEENT: atraumatic/normocephalic, PERRL, b/l nares congested with sniff test - no discharge noted. throat non-erythematous.no exudate, no swelling. Sinuses non-tender to palpation Neck: no swelling, no stridor CV: regular rate and rhythm, normal S1/S2, no murmurs Pulm: clear to auscultation bilaterally with no wheezes/rales Ext: moves all 4 spontaneously, no edema Skin: no visible lesions or rashes Neuro: CN II-XII grossly intact, b/l grip strength 5/5 Psych: appropriated, throughs linear A/P: 23 yo Patient with nasal congestion s/p 2nd Moderna COVID-19 vaccination. Congestion tolerable and patient comfortable with leaving clinic on own accord.
-abnormal reaction to covid-19 vaccination, states having lip swelling, body swelling, red rash in upper extremities, itching, chest tightness that resolved at the end of the day. -had an adverse reaction to 1st covid vaccine, pfizer, had facial swelling, leg and arm swelling, resolved after 24 hours
I received my 3 shot (Booster) at 3:40 PM on Sunday the 12th of December. Monday had mild symptoms, Minor body Aces and tired. However, Tuesday Moring the 14th at 4 AM I was woken by a sore dry mouth, when I went into the bathroom I seem my Lips were very swollen.  I woke my wife who called my daughter who a nurse. She recommended Benaydryl. It seemed the swelling was limited to only my lips. The Benydryl did cause the swelling to start going down after a few hours. I called my primary Dr office, and they wanted to make sure no more swelling or trouble breathing. I confirmed only swollen lips. They confirmed Benydryl and wanted me to report this to the CDC. I received a follow up call hours later checking on me and it seemed the swelling was slowly going down.
Patient reports that legs gave out when standing/walking 3 times over the past day. He has also had the chills and fever-like symptoms. He went to urgent care on 10/20/12 and had a CT scan and blood pressure taken with negative results. MD told to him to watch for any other symptoms.
Aortic valve endocarditis with MSSA, NSTEMI, Atrial fibrillation. Patient will likely require valve replacement
Local reaction ( L ) arm. Tx - ibuprofen 300 mg q 6 hours x 48 hours. BENADRYL 25-50 mg q 6 hours prn x 48 hours.
runs very high fever 102 to 105 went to ER; MD prescribed Cefcol & Pediaprophin;
started sore (vaccinated arm) right after the 1st dose; This is a spontaneous report from a contactable consumer (patient) received via a Pfizer sponsored program. A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, administered in arm, on an unspecified date (Batch/Lot number was unknown) (at the age of 69 years old) as dose 1, single for COVID-19 immunisation. Medical history included shaking/ shakes; allergic to hornets and yellow jackets. Concomitant medications included primidone; spironolactone. The patient started sore (vaccinated arm) right after the 1st dose on an unspecified date (reported as Tuesday). The patient reported that by the night of vaccination day, if not earlier, her arm wasn't hurting anymore. The patient recovered from the event on an unspecified date.  The lot number for BNT162B2, was not provided and will be requested during follow-up.
Have felt shaky with muscle twitches since day 1.  I would describe as similar to being on a low dose of steroids'.
Red swollen hive near the injection site.   It is hot to the touch, firm under the skin.  Appeared one week after I received the shot.
Patient experienced extreme itching on day 1 and had a few "mosquito bite" type bumps appear on back of neck and eyebrow (6-8 total).
Received shot at 7:45 11:00 had a headache at back of head 1:00 started to have chills 2:15 realized I had a fever and chills fever and chills until about 3am
Patient came to pharmacy on 11/08/2018 for her second SHINGRIX dose. Her first dose was administered on 06/29/2018. She stated the first dose gave a red circle around the immunization spot and got significantly larger the next day. She stated it was hot to the touch and had pain associated with it as well. She said at the time she did not know if it was from the shot or maybe a spider bite so she went to an urgent care and had them look at it and they prescribed her antibiotics. She said she had pain that radiated down her arm for months after. Based on her description of the pain and size of the red spot I was concerned about giving the second dose. I consulted with our clinical services manager and we determined that it was likely just the typical adverse effects listed on the product information and should proceed with the second dose. We also discussed counseling the patient on this as well as having her take a BENADRYL, ibuprofen, and applying a cold compress after receiving the dose. I did this and verified the patient was still wanting to receive the second dose. She stated she would like to and I made these recommendations to her. I also informed her that I would follow up the next day to see how she was feeling.
feeling dizzy; mild flu like symptoms; Chills; temperature of 100.6F; little soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (little soreness), DIZZINESS (feeling dizzy), INFLUENZA LIKE ILLNESS (mild flu like symptoms), CHILLS (Chills) and PYREXIA (temperature of 100.6F) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced PAIN IN EXTREMITY (little soreness), INFLUENZA LIKE ILLNESS (mild flu like symptoms), CHILLS (Chills) and PYREXIA (temperature of 100.6F). On 14-Apr-2021, the patient experienced DIZZINESS (feeling dizzy). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (little soreness), DIZZINESS (feeling dizzy), INFLUENZA LIKE ILLNESS (mild flu like symptoms), CHILLS (Chills) and PYREXIA (temperature of 100.6F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Apr-2021, Body temperature: 100.6 (Inconclusive) 100.6 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information included Tylenol.
pt recv vax & exp an inj site rxn described as a 6x3" area w/redness, swelling & warmth p/vax;rxn described as very hot & dizzy;approx 3min p/vax;next day arm was red & swollen & hot to touch;
FEELING UNWELL; TIRED; MILD HEADACHE; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 07-APR-2021 in left arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On APR-2021, the subject experienced feeling unwell. On APR-2021, the subject experienced tired. On APR-2021, the subject experienced mild headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the feeling unwell, tired and mild headache was not reported. This report was non-serious.
Hives or welts on upper back; Itchy; Hive or welts on legs and butt; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hive or welts on legs and butt), URTICARIA (Hives or welts on upper back) and PRURITUS (Itchy) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and Acid reflux (esophageal). Concomitant products included BUSPIRONE, FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) and CALCIUM CARBONATE (TUMS [CALCIUM CARBONATE]) for an unknown indication.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced URTICARIA (Hive or welts on legs and butt). On 21-Mar-2021, the patient experienced URTICARIA (Hives or welts on upper back) and PRURITUS (Itchy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Urticaria, at an unspecified dose and frequency. On 20-Mar-2021, URTICARIA (Hive or welts on legs and butt) had resolved. On 21-Mar-2021, URTICARIA (Hives or welts on upper back) had resolved. At the time of the report, PRURITUS (Itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included blood pressure medication and acid reflux medication.  Treatment information provided  included applied a cold ice pack.
Flu shot 06Dec. pt c/o sore throat 09Dec90.  On 10Dec90 c/o congestion in head, sneezing & hot & cold spells at night & pressure in sinus area. PMD visit throat culture -negative. Rx for sinus infection. Felt better.
An employee noticed two unopened vials of lyophilized vaccine component (ActHIB vaccine) without the liquid vaccine component (DTaP-IPV component). We cannot say with 100% certainty which two out of five patients were effected by the error and which MA is responsible. Vaccines with Lot #UJ876AA was entered into EMR on 06/21/2023. We narrowed our search down to the five patients that were given the Pentacel after 06/21/2023. Five vials come in a box. Two were missing the liquid component, one was given to a patient on the day the incident was discovered and two remained in the box. According to a report that was pulled, it shows commercial vaccines were given where Vaccines should have been given or it was documented incorrectly. An action plan has been put into place to prevent future errors. There will be inventory checks performed bi-weekly with an inventory check list and sign off for accountability. The staff is also keeping a log of vaccine administration to cross check the administration of the vaccines are accurate and match in the EMR. Dr. reviewed the patients chart and she is up to date with her vaccines and revaccination is not required for this patient.
Pt. states that after receiving the 1st dose of J&J 03/18/2021, started experiencing symptoms 03/19/2021 twitching in the left hand (currently), black and blue bruising in the left hand (subsided), and pain at injection site. Primary visit 05/2021 no recommendations just observations.
Engerix-b Adult instead of Engerix-B Ped vaccine; Engerix-b Adult instead of Engerix-B Ped vaccine; Engerix-b Adult instead of Engerix-B Ped vaccine; Engerix-b Adult instead of Engerix-B Ped vaccine; This non-serious case was reported by a other health professional via call center representative and described the occurrence of adult product administered to child in a 18-year-old female patient who received HBV (Engerix B adult) for prophylaxis.   Co-suspect products included HBV (Engerix B adult) for prophylaxis.   On 07-NOV-2023, the patient received the 2nd dose of Engerix B adult. On 09-OCT-2023, the patient received the 1st dose of Engerix B adult. On 09-OCT-2023, not applicable after receiving Engerix B adult and an unknown time after receiving Engerix B adult, the patient experienced adult product administered to child (Verbatim: Engerix-b Adult instead of Engerix-B Ped vaccine) and overdose (Verbatim: Engerix-b Adult instead of Engerix-B Ped vaccine). On 07-NOV-2023, the patient experienced adult product administered to child (Verbatim: Engerix-b Adult instead of Engerix-B Ped vaccine) and overdose (Verbatim: Engerix-b Adult instead of Engerix-B Ped vaccine). The outcome of the adult product administered to child, overdose, adult product administered to child and overdose were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 7-NOV-2023 The reporter was a medical assistant who stated about an 18 years old patient who received first and second doses of Engerix-b Adult instead of Engerix-B Pediatric vaccine.  According to the reporter the patient was doing fine, and the treating physician was aware. The reporter consented to follow up. The patient received a first and second doses of Engerix B adult instead of Engerix-B Pediatric vaccine, which led to the adult product administered to child and overdose.
Bursitis in the shoulder of the arm where vaccine was given.  Treated with ibuprofen and range of motion.  Still causing some discomfort three months after the shot.  Range of motion treatment seems to be helping. Second shot given on September 17, 2021 in same arm, no worsening of bursitis symptoms.  Redness around site of shot, swelling, and soreness lasted five days.
Pfizer-BioNTech COVID-19 Vaccine: One day after receving vaccine patient awoke with myalgias, fatigue, fever (maximum temperature: 100 degrees Fahrenheit), headache, and rhinorrhea. Patient was evaluated via telehealth two days after vaccine administration and denied throat pain, chest pain, chest tightness, or wheezing. No difficulty swallowing or breathing. Patient was instructed to follow-up with a health care provider immediately for worsening, persistent, or concerning symptoms.
Right arm redness, tender, fever and pain after Pneumovax injection after 12/09/11.
a case of the runs; Mild headache; Raging fever during the night; Chills; This spontaneous case was reported by a physician and describes the occurrence of ADVERSE EVENT (a case of the runs), PYREXIA (Raging fever during the night), CHILLS (Chills) and HEADACHE (Mild headache) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced PYREXIA (Raging fever during the night) and CHILLS (Chills). On 28-Jan-2021, the patient experienced ADVERSE EVENT (a case of the runs) and HEADACHE (Mild headache). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. On 29-Jan-2021, ADVERSE EVENT (a case of the runs), PYREXIA (Raging fever during the night), CHILLS (Chills) and HEADACHE (Mild headache) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported by the reporter.
I experienced runny nose, congestion, headaches, fever of 102, ear aches and mouth aches.
Pt recv vax on 10/9/98; 1 hr post vax pt exp congestion, achy, chills, fever, flu-like sx, mono, tonsillitis
Became pregnant July 15, 2021 and was diagnosed with fetal acrania on October 12, 2021. No previous history of fetal abnormalities.
Cluster of seizures lasting 1 - 1.5 hours, focal tonic seizures with fencer pose. Patient was taken to ER by EMS and given anti-seizure medication (Midazolam and Keppra). Patient was hospitalized after event. Patient discharged on Keppra.
PT DOES NOT SHOW ANY ADVERSE REACTION AS OF NOW. PT WAS GIVEN A BOOSTER SHOT 2 MONTHS AFTER THE SECOND VACCINATIONS.
patient was dizzy.  She had not eaten all morning.  we gave her coke and crackers and she was doing fine before she left.
Within six hours, I began feeling feverish with chills, nauseous, fatigued, and got a headache. My temperature at 7:56 p.m. was 100.7 degrees Fahrenheit.
This case was reported by a nurse via call center representative and described the occurrence of fever in a 32-year-old male patient who received BOOSTRIX (batch number X9YP3, expiry date October 2020) for prophylaxis. On 13th July 2018, the patient received BOOSTRIX. On 13th July 2018, less than a day after receiving BOOSTRIX, the patient experienced fever, night sweat, injection site pain, general body pain and headache. In July 2018, the patient experienced swelling. On an unknown date, the outcome of the fever, swelling, night sweat, injection site pain, general body pain and headache were unchanged. The reporter considered the fever, swelling, night sweat, injection site pain, general body pain and headache to be related to BOOSTRIX. Additional details were provided as follows: The report stated that the patient contacted her one day before the day of reporting to report the side effects. The patient received SHINGRIX on right deltoid. In July 2018, less than a week after receiving BOOSTRIX the patient experienced swelling. The patient explained that he had a fever of 102 degrees F since the past three days from the date of reporting. The pain and soreness experienced was at the injection site. The reporter had patients waiting for her to see, so the call was ended.
Arthralgia (Joint Pain) - Anti-inflammatory med: Ibuprofen; 600mg every 6 hours. Prednisone; 40mg daily x 5days.
Patient reported tongue sensation after 15 minutes of observation. No evidence of facial swelling or tongue  edema on exam. She denied throat tightness/itching, shortness of breath, or worsening symptoms. She  declined to stay beyond 15 minute interval as she stated she was feeling anxious. Reviewed s/sx   anaphylaxis, advised her to call 911 if these occur. She remained well appearing and was speaking clearly   in full sentences throughout observation.